These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

288 related items for PubMed ID: 22340222

  • 1. Efficacy and safety of itraconazole as empirical antifungal therapy in febrile neutropenic patients with hematologic malignancies: an open-lable, multicenter, observational trial in a Chinese cohort.
    Cheng S, Zhou JF, Zou P, Huang XJ, Jin J, Shen ZX.
    Chin Med J (Engl); 2011 Nov; 124(22):3670-5. PubMed ID: 22340222
    [Abstract] [Full Text] [Related]

  • 2. Efficacy and safety of micafungin versus intravenous itraconazole as empirical antifungal therapy for febrile neutropenic patients with hematological malignancies: a randomized, controlled, prospective, multicenter study.
    Jeong SH, Kim DY, Jang JH, Mun YC, Choi CW, Kim SH, Kim JS, Park JS.
    Ann Hematol; 2016 Jan; 95(2):337-44. PubMed ID: 26596974
    [Abstract] [Full Text] [Related]

  • 3. An open-label randomized trial comparing itraconazole oral solution with fluconazole oral solution for primary prophylaxis of fungal infections in patients with haematological malignancy and profound neutropenia.
    Glasmacher A, Cornely O, Ullmann AJ, Wedding U, Bodenstein H, Wandt H, Boewer C, Pasold R, Wolf HH, Hänel M, Dölken G, Junghanss C, Andreesen R, Bertz H, Itraconazole Research Group of Germany.
    J Antimicrob Chemother; 2006 Feb; 57(2):317-25. PubMed ID: 16339606
    [Abstract] [Full Text] [Related]

  • 4. The relationship between the success rate of empirical antifungal therapy with intravenous itraconazole and clinical parameters, including plasma levels of itraconazole, in immunocompromised patients receiving itraconazole oral solution as prophylaxis: a multicenter, prospective, open-label, observational study in Korea.
    Kim JS, Cheong JW, Kim YK, Park J, Mun YC, Kang HJ, Yi HG, Lee JH, Kim YS, Ryoo HM, Kim SH, Kim HY, Kim JY, Lee DG, Kim HG, Kim H, Joo YD, Min YH.
    Ann Hematol; 2014 Jan; 93(1):33-42. PubMed ID: 23807252
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Empirical versus preemptive antifungal therapy for high-risk, febrile, neutropenic patients: a randomized, controlled trial.
    Cordonnier C, Pautas C, Maury S, Vekhoff A, Farhat H, Suarez F, Dhédin N, Isnard F, Ades L, Kuhnowski F, Foulet F, Kuentz M, Maison P, Bretagne S, Schwarzinger M.
    Clin Infect Dis; 2009 Apr 15; 48(8):1042-51. PubMed ID: 19281327
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Efficacy and safety of micafungin as an empirical antifungal therapy for suspected fungal infection in neutropenic patients with hematological disorders.
    Yoshida M, Tamura K, Imamura M, Niitsu Y, Sasaki T, Urabe A, Ohyashiki K, Naoe T, Kanamaru A, Tanimoto M, Masaoka T.
    Ann Hematol; 2012 Mar 15; 91(3):449-57. PubMed ID: 21894476
    [Abstract] [Full Text] [Related]

  • 14. [Clinical efficacy and safety of itraconazole injection/oral solution sequential therapy for treatment of invasive fungal infection in intensive care unit].
    Collaborative Research Group of Efficacy and Safety of Itraconazole in Intensive Care UnitDepartment of Critical Care Medicine, Zhong-Da Hospital and School of Clinical Medicine, Southeast University, Nanjing 210009, China. haiboq2000@yahoo.com.cn, Qui HB.
    Zhonghua Nei Ke Za Zhi; 2008 Dec 15; 47(12):1012-6. PubMed ID: 19134307
    [Abstract] [Full Text] [Related]

  • 15. [Sequential intravenous and oral itraconazole in treatment of invasive fungal infection in hematological diseases].
    Group of Itraconazole Multi-Central Clinical TrialDepartment of Hematology, Ruijin Hospital Affiliated to Shanghai Jiaotong University Medical College, Shanghai 200025, China. rjchenyu@tom.com, Chen Y, Shen ZX.
    Zhonghua Nei Ke Za Zhi; 2008 Dec 15; 47(12):1026-9. PubMed ID: 19134310
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Efficacy and safety of intravenous itraconazole followed by oral itraconazole solution in the treatment of invasive pulmonary mycosis.
    Zhang YY, Zhou X, National Collaborative Group of Sequential Itraconazole Treatment for Invasive Pulmonary Mycosis.
    Chin Med J (Engl); 2011 Oct 15; 124(20):3415-9. PubMed ID: 22088546
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.